Cancer Type: Cutaneous
Study Type: Treatment
NCT#: NCT04975152
Phase: Phase I
Principal Investigator: Tarhini, Ahmad
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma: Safety and Biomarker Analysis
A safety and biomarker study that will enroll 30 subjects, 15 with clinical stage I-II Merkel Cell Carcinoma and 15 with locoregionally advanced CSCC either newly diagnosed or previously diagnosed and presenting with recurrent disease.
Primary: Evaluate the safety of neoadjuvant and adjuvant Cemiplimab in patients with stages I-II Merkel cell carcinoma both newly diagnosed or previously diagnosed and presenting with recurrent disease. (2) Evaluate the safety of neoadjuvant and adjuvant Cemiplimab in patients with operable locoregionally advanced CSCC both newly diagnosed or previously diagnosed and presenting with recurrent disease.
Immunotherapy; Surgery
Cemiplimab (); REGN2810 (Cemiplimab)
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.
Back to top
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate button below. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub
Our patient services specialists can assist you with scheduling an appointment, questions about medical records, insurance, billing and more.
Patient Appointment Center Hours: 7 a.m. to 7 p.m. Monday - Friday; 8 a.m. to noon Saturday